Panacea Innovation Limited 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-21 6:00 pm Purchase | 2025-05-16 | 13D | Atara Biotherapeutics, Inc. ATRA | Panacea Innovation Limited | 1,638,565 19.990% | 1,638,565 (New Position) | Filing |